David M Smadja is an expert in Hematology at Assistance Publique - Hôpitaux de Paris (France). As of October 2026, ScienceLeadR ranks David M Smadja in the top 1% of experts worldwide for COVID-19, Embolism and Thrombosis and Coronavirus Infections. David M Smadja has authored 371 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 1,557 (community average: 125). How the SLR is computed.

LeadR Profile

1 557 ScienceLeadR Reputation 1557
Network Map

Hematology

Subspecialties: Biochemistry - Pulmonology - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Hôpital Européen Georges-Pompidou

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 371

Citations

Citations: 12 651 1st author: 84 Last author: 103 Unique author: 16


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Reply to Wang et al.: Complementing the picture: adding antithrombin III monitoring in extracorporeal carbon dioxide removal.
PMID 42885556 — antithrombins, antithrombin iii, critical care
Am J Respir Crit Care Med20260
Auto-regulated bioprosthetic total artificial heart as bridge to transplantation: the EFICAS study.
PMID 42670784 — hemorrhage, stroke, heart, cardiology, heart transplantation, hemolysis, transplants, heart, artificial, transplantation
Eur Heart J Top journal20260
Bleeding, thrombosis, and anti-Xa monitoring in danaparoid-treated patients with suspected heparin-induced thrombocytopenia: a retrospective single-center study.
PMID 42657940 — hematology, hemorrhage, heparin, thrombosis, thrombocytopenia
Haematologica20260
Real-World Hemocompatibility Outcomes With Aspirin Omission in a Novel Fully Magnetically Levitated Left Ventricular Assist Device.
PMID 42628015 — hemorrhage, aspirin, thrombosis, warfarin
ASAIO J20262
Soluble ST2 dynamics are associated with delayed hospital discharge in COVID-19 patients: a joint-modeling analysis of the DisCoVeRy trial's longitudinal data.
PMID 42567228 — recycling, microbiology, biomarkers, covid-19, parasitic diseases, communicable diseases, infections
Clin Microbiol Infect20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5
Phase 1 1
Phase 3 1

By status:

Completed 4
Unknown 2
Suspended 1

By type:

Observational 4
Interventional 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 3
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map